Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Softtline motivates top management with 20 mln shares

1/25/24 SOFL

Ozon plans to open a sorting center in Blagoveshchensk

1/25/24 OZON

Repairs at the plant in Ust-Luga will take about two months

1/25/24 NVTK

MTS sold its business in Armenia

1/24/24 MTSS

INARCTICA in 2023 increased fish sales by 10%

1/24/24 AQUA

En+ Group evaluated investments in a 1 GW wind farm in Priamurye region

1/24/24 ENPG

HeadHunter has increased its stake in Dream Job

1/24/24 HEAD

Novatek resumes loading of oil products at the terminal in Ust-Luga

1/24/24 NVTK

X5 Group's revenue in 2023 increased by 20.8%

1/24/24 X5

VTB record growth in the number of active retail customers

1/24/24 VTBR